Why is the Plasmodium falciparum hexose transporter a promising new drug target?

By Joët T   Morin C   Fischbarg J   Louw Abraham I   Eckstein-Ludwig U   Woodrow C   Krishna S  

Expert Opinion on Therapeutic Targets, Vol. 7, Iss. 5, 2003-10 ,pp. : 593-602

Informa Healthcare

Access to resources Recommend Favorite

New 4-aminobicyclo[2.2.2]octane derivatives and their activities against Plasmodium falciparum and Trypanosoma b. rhodesiense

By Seebacher W.   Brun R.   Weis R.  

European Journal of Pharmaceutical Sciences, Vol. 21, Iss. 2, 2004-02 ,pp. : 225-233

Elsevier

Access to resources Recommend Favorite

Antiprotozoal Activity Against Plasmodium falciparum and Trypanosoma cruzi of Aeroplysinin-1 Isolated from the New Sponge Aplysina chiriquensis

By Gutiérrez Marcelino   Capson Todd   Guzmán Héctor   González José   Ortega-Barría Eduardo   Quiñoá Emilio   Riguera Ricardo  

Pharmaceutical Biology (Formerly International Journal of Pharmacognosy), Vol. 43, Iss. 9, 2005-12 ,pp. : 762-765

Informa Healthcare

Access to resources Recommend Favorite

Using expression information to discover new drug and vaccine targets in the malaria parasite Plasmodium falciparum

By Young Jason A   Winzeler Elizabeth A  

Pharmacogenomics, Vol. 6, Iss. 1, 2005-01 ,pp. : 17-26

Future Medicine

Access to resources Recommend Favorite

3-Aminosterol Compounds as a New Class of Anti-Malarial Agents against Chloroquine-Susceptible and -Resistant Plasmodium falciparum

By  

Letters in Drug Design & Discovery, Vol. 6, Iss. 2, 2009-03 ,pp. : 163-166

Bentham Science Publishers

Access to resources Recommend Favorite